Congestive Heart Failure During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-mutant Non-small Cell Lung Cancer (NSCLC)

We herein report a case of congestive heart failure which developed during osimertinib treatment. A 78-year-old woman presented with mild exertional dyspnea three weeks after starting osimertinib for the treatment of epidermal growth factor receptor (EGFR) T790M-positive non-small cell lung cancer....

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Intern Med
Auteurs principaux: Watanabe, Hiromi, Ichihara, Eiki, Kano, Hirohisa, Ninomiya, Kiichiro, Tanimoto, Mitsune, Kiura, Katsuyuki
Format: Artigo
Langue:Inglês
Publié: The Japanese Society of Internal Medicine 2017
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5596283/
https://ncbi.nlm.nih.gov/pubmed/28781309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.8344-16
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires